ArticleMolecular cancer therapeutics2020

Combinatorial Inhibition of Focal Adhesion Kinase and BCL-2 Enhances Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia.

Xiangmeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.